The Evolving Landscape in Mantle Cell Lymphoma

EP. 1: Accurately Diagnosing Mantle Cell Lymphoma

January 19th 2021

EP. 2: Treatment Approaches in Mantle Cell Lymphoma

January 19th 2021

EP. 3: Go-To Treatment Regimens in Mantle Cell Lymphoma

January 26th 2021

EP. 4: Lenalidomide and Bortezomib for Mantle Cell Lymphoma

January 26th 2021

EP. 5: BTK Inhibitors for Relapsed Mantle Cell Lymphoma

February 2nd 2021

EP. 6: Acalabrutinib and Zanubrutinib for Relapsed MCL

February 2nd 2021

EP. 7: Selecting a BTKi for Relapsed MCL Treatment

February 9th 2021

EP. 8: BTK Inhibitors for Relapsed MCL: Important Considerations

February 9th 2021

EP. 9: Venetoclax in Mantle Cell Lymphoma

February 16th 2021

EP. 10: CAR T-Cell Therapy for R/R Mantle Cell Lymphoma

February 16th 2021

EP. 11: Emerging BTK Inhibitors in Mantle Cell Lymphoma

February 23rd 2021

EP. 12: MCL: Emerging BTKi-Combination Approaches

February 23rd 2021

EP. 13: Novel Therapies in the Pipeline in Mantle Cell Lymphoma

March 2nd 2021

EP. 14: MRD Assessment in Mantle Cell Lymphoma

March 2nd 2021

EP. 15: Next Steps in Mantle Cell Lymphoma

March 2nd 2021